Related Experiment Video
Updated: Nov 5, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Parechovirus Infection in Early Childhood and Association With Subsequent Celiac Disease
German Tapia1, Kateřina Chudá, Christian R Kahrs
11Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway; 2Department of Paediatric, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; 3Department of Pediatrics, Østfold Hospital Trust, Grålum, Norway; 4Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg and Queen Silvia Children's Hospital, Gothenburg, Sweden; 5Division of Institute Resources, Department of IT and e-health, Norwegian Institute of Public Health, Oslo, Norway; 6Department of Pediatric Research, Oslo University Hospital, Oslo, Norway.
Insights
Early-life parechovirus infections were linked to a higher risk of developing celiac disease (CD) in children genetically predisposed to the condition. This study highlights parechovirus as a potential factor in celiac disease development.
Area of Science:
- Virology
- Gastroenterology
- Immunology
Background:
- Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals.
- Enteric viruses are common in early childhood, and their role in immune-mediated diseases is under investigation.
- Previous research suggests a potential link between viral infections and the development of autoimmune conditions.
Purpose of the Study:
- To investigate the association between parechovirus and anellovirus infections and the subsequent development of celiac disease (CD).
- To determine if increased frequency of parechovirus infections precedes the development of transglutaminase 2 (TG2) antibodies in children who later develop CD.
- To explore anellovirus as a potential marker of immune status in relation to CD development.
Main Methods:
- A matched case-control study nested within a longitudinal birth cohort (MIDIA study) of genetically at-risk children.
- Retrospective analysis of blood samples for TG2 antibody development and monthly stool samples for viral quantification using real-time PCR.
- Matching of 25 CD cases with 50 control children based on follow-up time, birthdate, and county of residence.
Main Results:
- Parechovirus was detected more frequently in stool samples from children who later developed CD, particularly before TG2 antibody development (adjusted odds ratio 1.67, P = 0.01).
- The association was stronger when samples were positive for both parechovirus and enterovirus (adjusted odds ratio 4.73, P = 0.02).
- Anellovirus was detected frequently but showed no significant difference between CD cases and controls.
Conclusions:
- Early-life parechovirus infections are associated with an increased risk of developing celiac disease in genetically predisposed children.
- Parechovirus may play a role in the pathogenesis of celiac disease.
- Anellovirus does not appear to be a significant factor or marker in the development of CD in this cohort.
Introduction:
To test whether parechovirus and anellovirus, frequent enteric viruses, were associated with subsequent celiac disease (CD). We hypothesized that children who later developed CD would have increased frequency of parechovirus infections before transglutaminase 2 (TG2) antibody development. Anellovirus testing was exploratory, as a potential marker of immune status.
Methods:
Matched case-control design nested within a longitudinal birth cohort (the MIDIA study) of children at genetic risk of CD (carrying the human leukocyte antigen genotype DR4-DQ8/DR3-DQ2, recruited throughout Norway during 2001-2007). We retrospectively tested blood samples taken at age 3, 6, 9, and 12 months, and then annually, to determine when TG2 antibodies developed. Of 220 genetically at-risk children tested, 25 were diagnosed with CD (cases; ESPGHAN 2012 criteria) and matched for follow-up time, birthdate, and county of residence with 2 randomly selected children free from CD (controls) from the cohort. Viruses were quantified in monthly stool samples (collected from 3 through 35 months of age) using real-time polymerase chain reaction methods.
Results:
Parechovirus was detected in 222 of 2,005 stool samples (11.1%) and was more frequent in samples from cases before developing TG2 antibodies (adjusted odds ratio 1.67, 95% confidence interval 1.14-2.45, P = 0.01). The odds ratio was higher when a sample was positive for both parechovirus and enterovirus (adjusted odds ratio 4.73, 95% confidence interval 1.26-17.67, P = 0.02). Anellovirus was detected in 1,540 of 1,829 samples (84.2%), but did not differ significantly between case and control subjects.
Discussion:
Early-life parechovirus infections were associated with development of CD in genetically at-risk children.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

